IVCA Conclave 2026 Marks 15 Years of Shaping India's Alternate Capital Ecosystem
NewsVoir
Mumbai (Maharashtra) [India], March 5: India's apex industry body for alternate capital, the Indian Venture and Alternate Capital Association (IVCA), will host the 15th edition of its flagship IVCA Conclave on 10-11 March 2026 in Mumbai. Since its inception, the Conclave has grown into one of the country's most influential forums for private capital, bringing together global investors, policymakers, and industry leaders to shape the direction of India's investment ecosystem.
Ashley Menezes, Partner and COO, ChrysCapital, and Chairperson, IVCA said, "The 15th edition of the IVCA Conclave is a meaningful milestone for our industry. Over the past decade and a half, India's alternate capital ecosystem has evolved from a promising segment into an essential pillar of economic development. What has stood out through this journey is the sector's growing depthstronger governance, constructive regulatory engagement, increasing domestic participation, and the confidence of global investors who now view India as a long-term allocation. It reflects years of collaboration, discipline, and institution-building."
Attendees and Partners
The IVCA Conclave will bring together institutional investors, limited partners, family offices, founders, operating leaders, policymakers, regulators, advisors, and ecosystem partners. Several senior government and regulatory leaders will join the two-day gathering, among them: Shri Tuhin Kanta Pandey, Chairman, Securities and Exchange Board of India (SEBI); Shri S Ramann, Chairman, PFRDA, Shri Sandip Pradhan, Whole-Time Member, SEBI; Smt. Ruchi Chojer, ED, SEBI, Smt. Nivruti Rai, CEO, Invest India; Shri Ananth Narayan, Former Whole-Time Member, SEBI, and Member, SAARC Committee, Pension Fund Regulatory and Development Authority (PFRDA); Shri Saravana Kumar, Director and Chief Executive Officer (SRI Fund), National Small Industries Corporation (NSIC); Shri Manish Diwan, Head - Biofoundry, NCR Biotech Cluster & IVCOL, Biotechnology Industry Research Assistance Council (BIRAC).
Sessions
Over two days, the Conclave will examine key themes through fireside chats, panel discussions, keynote addresses, report presentations, and an awards ceremony. Discussions will span key topics such as India's positioning in institutional portfolios, macro trends and PE outlooks, the growing role of domestic capital, and how alternate capital is financing climate innovation and AI. Sessions will also focus on capital allocation, governance frameworks, liquidity pathways, and the long-term investment priorities shaping India's growth trajectory.
The Indian Venture and Alternate Capital Association (IVCA) is a not-for-profit, apex industry body promoting the alternate capital industry and fostering a vibrant investing ecosystem in India. IVCA is committed to supporting the ecosystem by facilitating advocacy discussions with the Government of India, policymakers, and regulators, resulting in the rise of entrepreneurial activity, innovation, and job creation in India and contributing towards the development of India as a leading fund management hub. IVCA represents 500+ funds with a combined AUM of over $350 billion. Our members are the most active domestic and global VCs, PEs, funds for infrastructure, real estate, credit funds, limited partners, investment companies, family offices, corporate VCs, and knowledge partners. These funds invest in emerging companies, venture growth, buyout, special situations, distressed assets, and credit and venture debt, among others.
Next Story